Delivery Order SPE2DB20D3103-SPE2DB23FL8C0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a delivery order valued at $2,269.84 for the supply of RITUXIMAB 500MG/50M 1S, a prescription medication. The award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency, and is not subject to any set-aside requirements. Amerisourcebergen is a large pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- The Defense Logistics Agency awarded a $37,180.20 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Rituxan Hycela (1,400 mg-23,400 11.7 mL), a biologic medication used in oncology and immunology treatment. This firm fixed-price delivery order, which represents no set-aside opportunity, is scheduled for completion by September 8, 2025, with performance taking place at the vendor's Conshohocken, Pennsylvania location. The award is classified as a child...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,718.02 firm fixed price contract is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML medical supplies. The contract has a period of performance through July 24, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This federal contract award is for a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $79,549.95, is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract covers the...
- This federal contract award, valued at $11,149.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, covers the delivery of a wide range of pharmaceutical products and medical supplies to support various government healthcare programs. The contract, valued at $3,249.94, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical. It is a delivery order issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $3,139.92. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract is for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $172,730.24, is for the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The award is part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $62,479.44 delivery order contract is for the supply of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract has a firm fixed price...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of a variety of medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract, valued at $22,573.10, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a total...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL8C0Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,738.40 delivery order is for the specialty drug Rituxan Hycela 1,400 mg-23,400 11.7 ML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by the parent company, Cencora, Inc., which enables efficient procurement of a wide range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, plays a critical role in supplying essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to various federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.7k | 12/6/22 |